EGFR and neoplasm: The procedure confirmed the strong classification accuracy of exon 18 EGFR with a median ROC-AUC of 0.94 (95% CI: 0.70–1.00) and the specific association between the exon 18 region and tumor shrinkage at week 12 (see Figure S2 and Text S1 for detailed procedure).